Compare AUDC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUDC | BCYC |
|---|---|---|
| Founded | 1992 | 2009 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.7M | 256.5M |
| IPO Year | 2000 | 2019 |
| Metric | AUDC | BCYC |
|---|---|---|
| Price | $8.57 | $2.90 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $9.17 |
| AVG Volume (30 Days) | 115.0K | ★ 402.5K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.05 | N/A |
| Revenue Next Year | $3.87 | N/A |
| P/E Ratio | $23.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.95 | $3.04 |
| 52 Week High | $11.74 | $7.83 |
| Indicator | AUDC | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 29.77 |
| Support Level | $8.27 | N/A |
| Resistance Level | $9.17 | $3.94 |
| Average True Range (ATR) | 0.49 | 0.18 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 34.19 | 5.05 |
AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.